Table 4 of
Altay, Mol Vis 2021; 27:757-767. Table 4 of
Altay, Mol Vis 2021; 27:757-767.
Table 4. Variables selected based on model b) including all predictors.
| Variables | Subset | OR | Lower 95% CI | Upper 95% CI | P- value |
|---|---|---|---|---|---|
| Age | 1.16 | 1.14 | 1.19 | 3.53E-36 | |
| Gender | Male versus female | 0.71 | 0.47 | 1.08 | 0.109 |
| APOE rs2075650 | GA versus AA | 0.76 | 0.47 | 1.24 | 0.273 |
| GG versus AA | 0.00 | 0.00 | N/A | 0.977 | |
| ARMS2 rs10490924 | TG versus GG | 2.21 | 1.44 | 3.38 | 0.0002 |
| TT versus GG | 4.93 | 2.90 | 8.39 | 3.92E-09 | |
| CFH rs800292 | GA versus GG | 0.36 | 0.23 | 0.57 | 7.60E-06 |
| AA versus GG | 0.68 | 0.26 | 1.78 | 0.43 | |
| CFH rs12144939 | TG versus GG | 0.24 | 0.13 | 0.42 | 6.28E-07 |
| TT versus GG | 0.15 | 0.04 | 0.62 | 0.008 | |
| CFI rs10033900 | TC versus CC | 1.60 | 1.00 | 2.56 | 0.051 |
| TT versus CC | 1.48 | 0.85 | 2.57 | 0.162 | |
| COL8A1 rs13081855 | GT versus GG | 1.55 | 0.98 | 2.47 | 0.064 |
| TT versus GG | 0.00 | 0.00 | N/A | 0.984 | |
| CYP24A1 rs15706692 | GA versus AA | 0.73 | 0.49 | 1.10 | 0.131 |
| GG versus AA | 1.32 | 0.75 | 2.34 | 0.340 | |
| LIPC rs10468017 | CT versus CC | 1.25 | 0.85 | 1.84 | 0.266 |
| TT versus CC | 0.52 | 0.22 | 1.26 | 0.149 | |
| SKIV2L rs4296082 | GA versus GG | 0.52 | 0.30 | 0.90 | 0.018 |
| AA versus GG | 0.14 | 0.02 | 1.32 | 0.086 | |
| TYR rs6213132 | TC versus TT | 0.81 | 0.52 | 1.26 | 0.354 |
| CC versus TT | 0.58 | 0.34 | 0.98 | 0.041 | |
| Smoking | Never versus ever | 1.43 | 0.95 | 2.15 | 0.083 |
| Rheumatoid Arthritis | Yes versus no | 2.35 | 1.30 | 4.27 | 0.005 |
| Corticosteroids | Daily versus Non-daily | 1.75 | 0.90 | 3.42 | 0.098 |
| Antiglaucomatous Drugs | Daily versus Non-daily | 2.10 | 0.98 | 4.49 | 0.055 |
| Past Sunlight Exposure | ≥8 h a day versus <8 h a day | 1.62 | 0.97 | 2.72 | 0.068 |